Editorials

Time to reconsider CD33 SNP for gemtuzumab response

Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, College of Pharmacy, UF Health Cancer Center, University of Florida, Gainesville
Division of Pediatric Hematology/Oncology, Fred Hutchinson Cancer Research Center, Seattle, Washington
Haematologica Early view May 27, 2021 https://doi.org/10.3324/haematol.2021.279043